MI HYUN CHOI: Open Payments
NPI 1760075030 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 39 payments from 20 companies in 2025. Trend: 2023 $321 · 2024 $675 · 2025 $942
Food & beverage: $768Education: $174
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $147 |
| Merck Sharp & Dohme LLC | 5 | $111 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| SEAGEN INC. | 1 | $75 |
| Daiichi Sankyo Inc. | 3 | $68 |
| PFIZER INC. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Lilly USA, LLC | 2 | $42 |
| Eisai Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
Products named: Trodelvy, KEYTRUDA, KISQALI, ENHERTU, DATROWAY, VERZENIO, Lenvima, Nubeqa.
Industry payments across GA — which companies pay providers there.
